Pi3k isoform selective inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 473/32 (2006.01) A61K 31/52 (2006.01) A61P 25/00 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2730271

2-Morpholin-4-yl-9H-purine and 5-Morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d] pyrimidine derivatives, especially those substituted by 6-heteroaryl, are unexpected P13 kinase isoform selective inhibitors with good drug properties and are useful in treating disorders related to abnormal P13K activities such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine disorders and neurological disorders.

La présente invention concerne des dérivés de la 2-morpholin-4-yl-9H-purine et de la 5-morpholin-4-yl-3H-[ 1,2,3]triazolo[4,5-d] pyrimidine, particulièrement ceux substitués par un groupe 6-hétéroaryle, inhibiteurs sélectifs inattendus de la PI3-kinase présentant de bonnes propriétés de médicament et étant utiles dans le traitement de troubles liés à des activités anormales de la PI3-kinase telles que le cancer, des troubles immunitaires, une pathologie cardiovasculaire, une infection virale, une inflammation, des troubles métaboliques/endocriniens et des troubles neurologiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pi3k isoform selective inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pi3k isoform selective inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pi3k isoform selective inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1794684

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.